A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants
Condition: Ebola Interventions: Biological: Ad26.ZEBOV; Biological: MVA-BN-Filo; Biological: Placebo Sponsor: Janssen Vaccines & Prevention B.V. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials